Disruption of Rho signaling results in progressive atrioventricular conduction defects while ventricular function remains preserved 1 LEI WEI * ,† ,‡ ,§ ,|| ,2 , GEORGE E. TAFFET * ,‡ ,|| , DIRAR S. KHOURY ¶ , JACQUELINE BO * ,‡ ,|| , YI LI || , ATSUKO YATANI # , M. CRAIG DELAUGHTER * , RAISA KLEVITSKY ** , TIMOTHY E. HEWETT ** , JEFFREY ROBBINS ** , LLOYD H. MICHAEL * ,‡ ,|| , MICHAEL D. SCHNEIDER * ,† ,§ , MARK L. ENTMAN * ,‡ ,|| and ROBERT J. SCHWARTZ * ,† ,‡ ,§ ,|| * Departments of Medicine, † Molecular and Cellular Biology, ‡ Section of Cardiovascular Sciences, § Center for Cardiovascular Development, || The DeBakey Heart Center, and ¶ Section of Cardiology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas, USA; # UMDNJ-New Jersey Medical School, Cardiovascular Research Institute, Newark, New Jersey, USA; and ** Molecular Cardiovascular Biology, Children’s Hospital Medical Center, Cincinnati, Ohio, USA 2 Correspondence: Cardiovascular Sciences Section, Department of Medicine, Room 506D, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. E-mail: lwei@bcm.tmc.edu <h3>SPECIFIC AIMS</h3> The aim of the present study was to explore the necessity
/lp/fed-of-american-socs-for-experimental-biology/disruption-of-rho-signaling-results-in-progressive-atrioventricular-SNbhNgiSOp